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Figure 1. Seven-day moving average number of COVID-19 cases, emergency
department visits, hospital admissions, and deaths – United States, * December 1,
2020-January 15, 2022

BACKGROUND
Central line-associated infections (CLABSI) are life-threatening
nosocomial infections that are associated with significant increase in
healthcare expenditure, prolonged stays, and risk of mortality.

From January to December 2021, there was a total of thirty-two
CLABSI across all units. The CLABSI rate for the ICU was 1.88 and
1.76 hospital-wide per 1,000 line days in 2021. Sixteen of the thirtytwo cases (50%) were COVID-19 positive with 59% of the infections
occurring between August and October (Figure 2). The most isolated
organism was Staphylococcus epidermis followed by Candida species
(Figure 3). Overall mortality rate for CLABSI in 2021 was 56%
(18/32). Further analysis revealed a mortality rate for COVID-19
positive patients with CLABSI in 2021 to be 87.5% and for COVID-19
negative patients with CLABSI to be 25%.

It is defined by the National Healthcare Safety Network (NHSN) as a
laboratory confirmed infection in patients with a central line that has
been in placed for 2 or more days prior to positive blood culture.
It is estimated that 30,100 CLABSIs occur annually in intensive care
units and wards across acute care facilities in the United States with a
mortality rate anywhere between 4-20%.
Figure 2. Incidence of CLABSI at South Texas Hospital from January 2021 to March
2022

AIMS
To identify outcome trends and risk factors that contribute to incidence
of central line-associated infections in an 866-bed hospital in South
Texas

From January to March 2022, there was a total of six CLABSIs cases.
The incidence rate for the ICU was 1.27 and 1.09 hospital-wide per
1,000 line days. Three of the six (50%) cases were COVID-19
positive. The most isolated organism was Staphylococcus aureus
(Figure 4). Overall mortality rate for CLABSI in 2022 from January to
March is 50%. Further breakdown showed a mortality rate for
COVID-19 positive patients with an associated central line blood
stream infection to be 66.7% and for COVID-10 negative patients with
an associated CLABSI to be 33.3%.

CONCLUSIONS

MATERIALS AND METHODS
A retrospective chart review was conducted on 38 patients who met
the NHSN criteria for CLABSI during the period of January 2021 to
March 2022 in order to identify risk factors and patient characteristics
that may have contributed to increase CLASBI incidence during this
period. Patient characteristics such as COVID-19 status, organism
isolated, and mortality rate was examined. Mortality was defined as
subjects expiring during the length of the hospital stay.

RESULTS

Figure 3.

Figure 4.

Additionally, CLABSI rate was calculated for ICU related infection
and hospital wide infection for each calendar year. The CLABSI rate
was calculated per 1,000 central line days by dividing the number of
CLABSIs by the total number of central line days and multiplying the
result by 1,000.
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In conclusion, the COVID-19 pandemic has had a significant impact
on incidence of central-line associated blood stream infection at this
866-bed hospital in South Texas. The trend of CLABSI cases within
this hospital system from January 2021 to March of 2022 closely
follows the incidence of COVID-19 cases reported in the United States
by the CDC (Figure 1 and Figure 2). The sharp increase in incidence
between August and October of 2021 at VBMC strongly coincides
with the COVID-19 Delta wave. Factors that contributed to this
include high hospital census as well as increased nurse turnover during
this timeframe. Additionally, during this time, there was an increased
incidence of coagulase-negative Staphylococcus infection. This
potentially suggests increased risk of central-line infections secondary
to sub-optimal aseptic practices due to inadequate training and nurse
shortages. Mortality rate for COVID-19 positive patients with
CLABSI infections were found to be higher than in COVID-19
negative patients for all time frames examined. Overall, this study has
demonstrated the need to implement continuous monitoring and
regular feedback on performance in order to address shortcomings that
may negatively impact health outcomes for hospitalized patients.

FUTURE DIRECTION
Retrospective chart review of CLABSI prior to the COVID-19 pandemic
needs to be performed in order to run statistical analysis to determine the
association between the COVID-19 pandemic with CLABSI events.

